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Abstract
Background: The increased survival of preterm and very low birth weight infants in recent years
has been well documented but continued surveillance is required in order to monitor the effects
of new therapeutic interventions. Gestation and birth weight specific survival rates most accurately
reflect the outcome of perinatal care. Our aims were to determine survival to discharge for a large
Canadian cohort of preterm infants admitted to the neonatal intensive care unit (NICU), and to
examine the effect of gender on survival and the effect of increasing postnatal age on predicted
survival.
Methods: Outcomes for all 19,507 infants admitted to 17 NICUs throughout Canada between
January 1996 and October 1997 were collected prospectively. Babies with congenital anomalies
were excluded from the study population. Gestation and birth weight specific survival for all infants
with birth weight <1,500 g (n = 3419) or gestation ≤30 weeks (n = 3119) were recorded. Actuarial
survival curves were constructed to show changes in expected survival with increasing postnatal
age.
Results: Survival to discharge at 24 weeks gestation was 54%, compared to 82% at 26 weeks and
95% at 30 weeks. In infants with birth weights 600–699, survival to discharge was 62%, compared
to 79% at 700–799 g and 96% at 1,000–1,099 g. In infants born at 24 weeks gestational age, survival
was higher in females but there were no significant gender differences above 24 weeks gestation.
Actuarial analysis showed that risk of death was highest in the first 5 days. For infants born at 24
weeks gestation, estimated survival probability to 48 hours, 7 days and 4 weeks were 88 (CI
84,92)%, 70 (CI 64, 76)% and 60 (CI 53,66)% respectively. For smaller birth weights, female survival
probabilities were higher than males for the first 40 days of life.
Conclusion: Actuarial analysis provides useful information when counseling parents and highlights
the importance of frequently revising the prediction for long term survival particularly after the first
few days of life.
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Background
The improvement in survival rates for preterm and very
low birth weight infants has been well documented dur-
ing the last 20 years [1-3]. More recently, a marked reduc-
tion in mortality rates has been reported following the
introduction and widespread use of antenatal steroids and
exogenous surfactant [4-6]. Despite initial concerns, stud-
ies of later neurodevelopmental outcome have not shown
an increase in major disability rates as a result of
improved survival [7-9]. As our understanding of disease
processes increases and new therapies continue to be
developed, continued surveillance of up to date outcome
data is essential in order to monitor the effectiveness of
current practice.
Early reports of survival rates for high risk infants were
based on birth weight alone, as assessment of gestational
age was relatively imprecise prior to the introduction of
routine first trimester ultrasound scans. Subsequently,
survival data based on gestational age has become more
widely reported [10,11]. This information is more useful
for obstetric decision-making in the prenatal period and
there is increasing evidence that mortality and later mor-
bidity in high risk infants relates more closely to gestation
than to birth weight [10,12]. Indeed a combination of
both variables may give an even more accurate prediction
of outcome once the infant is born [13].
Of further concern is that survival data in many published
studies is derived from single tertiary units or collabora-
tions of such centres which are not geographically based
[1,14]. This increases the likelihood of sample bias and
may not give a true reflection of survival expectations for
the population as a whole. The effects of gender and mul-
tiple births on survival have also been of interest in previ-
ous studies, many showing higher survival rates for
females and/or singletons [11,15-19]. This additional
information may enhance our prediction of survival
based on gestation or birth weight alone. More recently,
attention has focused on the timing of infant death, spe-
cifically utilising actuarial survival analysis to predict
future life expectancy from a given age [20-23]. This pro-
vides useful additional information when making deci-
sions regarding ongoing management in the neonatal
intensive care unit (NICU).
Our aims were to determine survival to discharge for a
large Canadian cohort of high-risk infants (<1500 g or
≤30 weeks) representing admissions to 17 NICUs with
75% of tertiary level NICU beds in Canada, and to exam-
ine the effects of gestation, birth weight, gender and mul-
tiple birth on survival. Utilizing actuarial survival analysis,
the effect of increasing postnatal age on expected survival
to discharge was investigated.
Methods
Study population
The Canadian Neonatal Network comprised 17 tertiary
NICUs across Canada in 1996 [24]. It was funded by the
Medical Research Council of Canada and other institu-
tions (see acknowledgements) in 1996 to facilitate neona-
tal research by creating a national neonatal-perinatal
database. The Canadian population in 1996 was about 30
million with approximately 357,000 births annually [25].
This study included all infants with a birth weight <1500
grams or gestational age ≤30 weeks who were admitted to
the Canadian Neonatal Network during a 22-month
period between January 1996 and October 1997. Infants
with congenital anomalies were excluded because they
have different mortality and morbidity risks [26].
Data collection
Prospective data were collected locally by trained research
assistants and transmitted electronically to the Canadian
Neonatal Network Coordinating Centre for verification
and analysis. Collected data included demographic varia-
bles, obstetric information, neonatal illness severity
(Score for Neonatal Acute Physiology, Version II [SNAP-
II]) [27], therapeutic intensity (Neonatal Therapeutic
Intensity Scoring System [NTISS]) [28] and selected out-
comes and resource use.
Definition of study variables
Study variables were defined according to the Canadian
Neonatal Network SNAP Project Abstractor Manual [29].
An admission was defined as a stay in the NICU for at least
24 hours or death/transfer to another unit within 24
hours. Gestational age was defined as the best obstetric esti-
mate based on early prenatal ultrasound, obstetric exami-
nation and obstetric history, unless the post-natal
pediatric estimate of gestation differed from the obstetric
estimate by more than two weeks. In that case, the pediat-
ric estimate of gestational age was used instead. An infant
was defined as small-for-gestational age (SGA) if the birth
weight was less than the 10th percentile for gestational age
according to the growth charts established by Arbuckle
[30] in 1989 for the Canadian population. SNAP-II [27] is
a neonatal illness severity score calculated from 6 empiri-
cally weighted physiologic measurements made during
the first 12 hours of admission to the NICU. NTISS [28] is
a score of neonatal therapeutic intensity calculated from a
checklist of 63 NICU therapies used in a 24 hour period,
weighted according to invasiveness and cost. Chronic lung
disease was defined as oxygen dependency at 36 weeks cor-
rected GA for an infant who was born at ≤32 weeks gesta-
tion [31]. Intraventricular hemorrhage (IVH) was defined
according to the criteria of Papile [32] from head ultra-
sound performed before 14 days of life. Necrotizing entero-
colitis (NEC) was defined according to Bell's criteria (stage
2 or higher) [33] and was classified as medical (clinicalBMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
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symptoms and signs plus evidence of pneumatosis on
abdominal X'ray) or surgical (histological evidence of
NEC on surgical specimen of intestine). Retinopathy of pre-
maturity (ROP) was defined according to the International
Classification for Retinopathy of Prematurity [34] and the
Reese Classification of cicatrical disease [35]. Nosocomial
infection was defined using blood and cerebrospinal fluid
culture results according to Freeman's criteria [36]. Patent
ductus arteriosus was defined as clinical diagnosis plus
treatment with indomethacin or surgical ligation or both.
Seizures were defined as clinically significant episodes wit-
nessed by a nurse or physician and for which anti-convul-
sant treatment was given. Congenital anomalies were
classified according to the WHO International Classifica-
tion of Diseases, 9 th Revision (ICD-9) [37].
Data analysis
Data analysis was carried out on two populations – pre-
term babies with gestation age ≤30 weeks and Very Low
Birth Weight (VLBW) babies with birth weight <1,500
grams. A two sample t-test was used to separately test the
effect of gender and multiple births on population demo-
graphics, adverse outcome and resource use. Similarly a
two sample t-test was used to test the effect of gender on
survival proportions for each week of gestational age and
each 100 grams birth weight range. For the actuarial anal-
ysis, the event of interest was death and the time-to-event
was the number of days survived. Babies that survived to
discharge had their length of stay included as right cen-
sored observations. The actuarial survival estimator which
estimates the probability of survival to and beyond a set
number of days was calculated in daily intervals for the
first 60 days of life. The effect of gender, gestation age and
birth weight on survival were studied by obtaining actuar-
ial survival estimators for each category. The probability
of survival to discharge, for an infant who has survived to
a given day in the NICU, was calculated and graphed by
gestational age and birth weight category.
Results
Between January 8, 1996 and October 31, 1997, 19,507
infants were admitted to participating NICUs. Excluding
those with congenital anomalies, there were 3,119 infants
≤30 weeks gestational age and 3,409 infants with birth
weight <1,500 grams. Characteristics of the two groups are
shown in Table 1. Of note, for infants <1,500 grams birth
weight, 52% were born by caesarean section, 21% were
outborn and 68% received antenatal steroids.
Survival to NICU discharge
Survival to discharge increased from 45% for infants
weighing <600 g at birth to over 95% for those with birth
weight >1200 g (Fig 1). There was a similar increase for
gestational age groups with survival increasing from about
14% at 22 weeks to over 93% at 28 weeks and above (Fig
2).
Effect of gender on survival and morbidity
When analysed by gestational age groups, survival for
male and female infants was not significantly different
Birth weight specific survival Figure 1
Birth weight specific survival.
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Table 1: Characteristics of preterm and very low birth weight (VLBW) infants in the study cohort
Preterm (≤30 weeks) VLBW (<1500 g)
n = 3119 n = 3409
Males (%) 56 53
Multiple births (%) 27 29
Cesarean section (%) 46 51
Antenatal steroids (%) 72 70
Outborn (%) 22 21
Small for gestational age 3 rd percentile (%) 14.7 26.1
Mean birth weight (grams) 1071 1041
Mean gestational age (weeks) 27 28BMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
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except for those born at 24 weeks gestation in whom sur-
vival for females was 17 (3, 29)% higher (Fig 3). When
analysed according to birth weight groups, survival for
females in the 600–699 g group was 7 (6,28)% signifi-
cantly higher than for males (Fig 4). However, within
many birth weight groups, females were significantly
more mature than males and would therefore be expected
to have higher survival as a consequence of gestational age
(Tables 2 and 3). In contrast to survival, female infants
had significantly (p < 0.05) lower incidence of chronic
lung disease and severe intraventricular hemorrhage than
male infants (Table 4). The high incidence of SGA among
infants born at <1,500 g reflects the inherent tendency to
select SGA infants when birth weight criteria is used to cat-
egorise infants instead of gestational age.
Multiple births and antenatal steroids
Of the 3119 infants born ≤30 weeks, 2,277 (73%) were
singleton deliveries and 841 (27%) were the products of
multiple gestation pregnancies (Table 5). There was no
significant difference in survival, illness severity or
resource use between the two groups. Antenatal steroid
use was 7(4,11)% higher in multiple gestation for VLBW
babies, and delivery by cesarean section was 9(5,13)%
more likely in multiple gestation pregnancies for VLBW.
Antenatal steroid use was 7(3,11)% higher in multiple
gestation for preterm babies, and delivery by cesarean sec-
tion was 9(6,13)% more likely in multiple gestation preg-
nancies for preterm. A full or partial course of antenatal
steroids was given to 70% of infants ≤30 weeks gestation
and to 68% of infants between <1,500 g birth weight. The
use of antenatal steroids was lower in the most preterm
infants ≤24 weeks gestation.
Actuarial survival
Actuarial survival curves are given in Figures 5, 6, 7, 8, 9
for the first 60 days. Points on the curves give S(t); the esti-
mated probability of a baby surviving to at least t days.
Babies that were discharged from the NICU can not afford
to be ignored as these were most likely to be the longer
lived observations. Babies that were discharged from the
NICU were therefore included as censored observations in
the analysis. By comparing the slope of the curve (which
gives the instantaneous risk of death), the highest risk of
death is within the first 6 days. Risk of death is higher for
smaller babies and babies with lower GA. Risk of death
also decreases with time. Figure 9 shows that actuarial sur-
vival is higher among females than males during the first
40 days, and narrows after that. Figures 10 and 11 give the
probability of survival to discharge for an infant who has
survived to a given day in the NICU, stratified by gesta-
tional age and birth weight respectively.
Discussion
Since our study is based on a large, geographically defined
Canadian cohort, it has greater relevance than those from
single units and provides a more realistic picture of neo-
natal outcomes. In addition, our study cohort was derived
from large regional centres with comparable levels of care
Table 3: Comparison of mean birth weight between male and 
female infants in each GA group (Preterm)
Weight (grams)
GA (weeks) Male Female p-value
n
23 105 625 576 <0.05
34 234 699 679 ns
25 329 765 755 ns
26 374 897 813 <0.05
27 388 1005 943 <0.05
28 466 1155 1102 ns
29 579 1311 1236 <0.05
30 612 1485 1382 <0.05
Gestational age specific survival Figure 2
Gestational age specific survival.
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Table 2: Comparison of mean gestational age (GA) between 
male and female infants in each birth weight group (VLBW)
Mean GA (weeks)
Birth Weight (g) Male Female p-value
n
<600 203 24.2 24.4 ns
600–699 303 24.7 25.5 <0.05
700–799 318 25.5 26.0 <0.05
800–899 344 26.3 27.1 <0.05
900–999 297 27.2 27.4 ns
1000–1099 375 28.2 28.6 ns
1100–1199 368 28.8 29.3 <0.05
1200–1299 381 29.4 29.9 <0.05
1300–1399 372 29.7 30.9 <0.05
1400–1499 448 30.7 31.0 nsBMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
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conforming to current North American standards for neo-
natal intensive care. Our results are similar to those from
previous publications on NICU outcomes, such as that of
the NICHD Neonatal Network [1-4], the Vermont-Oxford
Trials Network [38,39] and the Australia-New Zealand
Neonatal Network [40] (although some networks exam-
ined all live born infants instead of NICU admissions).
Although improvement in survival rates were previously
reported among the most preterm groups [1-4,24,38-40],
more recent publications report no further improvement
in outcomes [41,42], and demonstrate the importance of
reporting trends over time.An advantage in survival for
female infants has been reported by previous studies with
the greatest difference apparent when stratified by birth
Male/Female survival by birth weight Figure 4
Male/Female survival by birth weight.
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Table 4: Male/Female characteristics of preterm (≤30 weeks gestation) and very low birth weight Infant (< 1,500 g) groups
Preterm (≤30 weeks gestation) Very low birth weight (< 1,500 g)
Male n = 1741 (56%) Female n = 1376 (44%) Male n = 1797 (53%) Female n = 1601 (47%)
Demographics
Mean birth weight (grams) 1102 1032* 1050 1031*
Mean gestational age (weeks) 27.4 27.4 27.9 28.3*
Small for gestational age (%) 13.6 16.1* 24.4 28.2*
5-minute Apgar score (mean) 7.2 7.3 7.2 7.4*
Outborn (%) 21.4 21.7 21.4 19.9
Antenatal steroids (%) 69.3 71.3 66.2 69.4*
SNAP-II (mean) 26.6 27.2 26.5 24.8*
Outcomes
Survival (%) 85.2 86.9 85.6 88.9*
Necrotizing enterocolitis (%) 6.5 7.0 6.6 6.3
Patent ductus arteriosus (%) 28.0 32.3* 27.3 28.8
Seizures (%) 4.6 4.9 4.5 4.2
Chronic lung disease (%) 25.1 21.7* 25.7 18.9*
Primary infection (%) 1.8 2.0 1.6 1.6
Nosocomial infection (%) 21.2 22.1 21.9 20.9
Intraventricular hemorrhage (≥grade 3) (%) 9.6 7.5* 9.1 6.4*
Retinopathy of prematurity (≥stage 3) (%) 10.9 10.8 10.5 9.7
Resource use
NTISS (mean) 17.5 17.1 17.1 16.0*
Assisted ventilation (%) 88.7 86.7 83.9 79.6*
Number of ventilated days (mean) 18.0 17.1 17.5 14.9*
Surgery (%) 21.2 14.5* 21.6 12.9*
Length of NICU stay (mean) (days) 48.1 48.9 47.6 45.7
* significant (p < 0.05) difference between male and female infants
Male/Female survival by gestational age Figure 3
Male/Female survival by gestational age.
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weight groups [41-44]. In contrast, when analysed by ges-
tational age, we found a gender difference in survival only
for infants born at 24 weeks GA or less. This may reflect
the fact that at any given birth weight, female infants tend
to be more mature. It has also been previously suggested
that the advantage in survival for female infants is related
to a more favourable hormonal milieu in the female fetus
leading to accelerated lung maturation compared to the
male [45-48]. In the present era, it is also possible that the
increased use of antenatal steroids and exogenous sur-
factant has improved overall survival but more notably in
male compared to female infants. However, not all gender
differences were eliminated and female infants continued
to have lower incidences of chronic lung disease and
severe intraventricular hemorrhage than male infants.
Actuarial survival analysis also showed that female infants
had lower mortality rates than male infants during the
first 40 days of life, indicating a difference in time of
death.
Actuarial analysis adds a further dimension to standard
survival data and highlights several points of interest. For
all gestational age and birth weight groups the risk of
death is greatest during the first few days of life with rela-
tively few deaths occurring after day 7. This emphasises
the importance of revising the chances of survival at regu-
lar intervals especially during the first few days of life (as
in figures 10 and 11). Such updated survival information
is useful when informing parents and is necessary for
ongoing management decisions. Furthermore, actuarial
survival curves are helpful when studying the economic
aspects of neonatal intensive care. The majority of deaths
occur during the first few days of life and therefore the
proportion of health care expenditure on eventual non-
survivors is relatively small. With reference to research and
health promotion, actuarial data aid the development of
treatment strategies. Our data highlights where interven-
tions would have the greatest benefit e.g. early deaths
within the first few days and late deaths after the first 28
Table 5: Characteristics of singleton and multiple birth preterm infants
Preterm (≤30 weeks gestation) Very low birth weight (< 1,500 g)
Singleton n = 2277 (73%) Multiple n = 841 (27%) Singleton n = 2424 (71%) Multiple n = 975 (29%)
Demographics
Mean birth weight (grams) 1071 1072 1031 1066
Mean gestational age (weeks) 27.3 27.6* 27.9 28.4*
Small for gestational age ( % ) 1 5 . 01 3 . 82 6 . 32 5 . 7
5-minute Apgar score (mean) 7.2 7.4* 7.2 7.5*
Outborn (%) 22.5 18.9* 21.9 17.6*
Antenatal Steroids (%) 68.2 75.4* 65.7 73.2*
SNAP-II (mean) 27.1 26.2 26.3 24.1*
Outcomes
Survival (%) 86.1 85.7 87.1 87.4
Necrotizing enterocolitis (%) 6.9 6.3 6.8 5.6
Patent ductus arteriosus (%) 29.6 30.9 28.1 28.0
Seizures (%) 5.3 3.2* 4.8 3.2*
Chronic lung disease (%) 24.4 21.7 23.4 20.2
Primary infection (%) 2.2 0.8* 1.9 0.9*
Nosocomial infection (%) 22.1 21.6 22.0 20.0
Intraventricular hemorrhage 
(≥grade 3) (%)
9 . 27 . 38 . 46 . 5
Retinopathy of prematurity 
(≥stage 3) (%)
12.1 7.4* 11.3 7.2*
Resource use
Caesarean section (%) 43.0 52.4* 48.7 57.7*
NTISS (mean) 17.3 17.3 16.8 16.1*
Assisted ventilation (%) 87.6 88.6 82.8 79.6*
Number of ventilated days (mean) 18.2 15.9* 17.1 14.1*
S u r g e r y  ( % ) 1 8 . 81 7 . 11 8 . 4 1 5 . 3 *
Length of NICU stay (mean) 
(days)
48.8 47.6 47.9 43.9*
* denotes p < 0.05 level of significanceBMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 7 of 13
(page number not for citation purposes)
days. The effects of new interventions on survival patterns
could then be monitored. Finally, this report extends the
available information on various aspects of low birth
weight infants previously reported by the Canadian Neo-
natal Network [24,26,27,49-58].
One limitation of our survival data is that they only
include infants admitted for neonatal intensive care. They
do not take into account stillbirths after the onset of pre-
term labour nor delivery room deaths of live born infants.
Therefore, they provide an overestimate of survival
chances if used to counsel parents during preterm labour
or as a guide to obstetric management. However, as most
high risk pregnancies are currently managed in large peri-
natal centres, with skilled personnel certified in neonatal
resuscitation, the majority of infants born at 24 weeks and
above are successfully resuscitated and admitted for inten-
sive care, and our results would be highly applicable to
them. Discharge policies may affect survival rates but
since infants are usually discharged only when they are
sufficiently well, it is unlikely that discharge policies will
significantly affect our results. For the actuarial survival
analysis, survival to 60 days of life was considered. How-
ever, deaths may occur even after this time during the
post-discharge period and these were not considered in
the study.
Conclusion
Up to date survival rates are essential when evaluating
perinatal services. Previously reported effect of gender on
overall survival are no longer apparent among infants >24
weeks gestation but there is a gender difference in the time
of death. Actuarial survival analysis emphasises the
importance of frequently revising predictions for survival
in high-risk infants, particularly during the first week of
life.
Abbreviations
BW Birth weight
GA Gestational age
NICU Neonatal intensive care unit
NTISS Neonatal therapeutic intensity scoring system
SNAP-II Score for Neonatal Acute Physiology, Version II
VLBW Very low birth weight
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
Huw Jones interpreted data and drafted the manuscript.
Stella Karuri performed statistical analysis and interpreta-
tion. Shoo K Lee was the principal investigator and inter-
preted the data and drafted the manuscript. Catherine
Cronin, Arne Ohlson and Abraham Peliowski and Anne
Synnes were site investigators. All these individuals read
and approved the final manuscript. The CNN represents
all site investigators, and was responsible for organization
and administration of the SNAP study, and subsequent
data flow.
Acknowledgements
This study was supported by Grant 40503 and Grant 00152 from the Med-
ical Research Council of Canada. Additional funding was provided by the 
B.C.'s Children's Hospital Foundation; Calgary Regional Health Authority; 
Dalhousie University Neonatal-Perinatal Research Fund; Division of 
Neonatology, Children's Hospital of Eastern Ontario; Child Health Pro-
gram, Health Care Corporation of St John's; The Neonatology Program, 
Hospital for Sick Children; Lawson Research Institute; Midland Walwyn 
Capital Inc; Division of Neonatology, Hamilton Health Sciences Corpora-
tion; Mount Sinai Hospital; North York General Hospital Foundation; Saint 
Actuarial survival curves stratified by gestation (weeks), by  gender Figure 5
Actuarial survival curves stratified by gestation (weeks), by 
gender.BMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 8 of 13
(page number not for citation purposes)
Joseph's Health Centre; University of Saskatchewan Neonatal Research 
Fund; University of Western Ontario; Women's College Hospital.
Members of the Canadian Neonatal Network: Shoo K. Lee (Coordi-
nator, Canadian Neonatal Network); Wayne Andrews (Charles A. Janeway 
Child Health Centre, St John's, NF); Ranjit Baboolal (North York Hospital, 
N. York, ON); Jill Boulton (St Joseph's Health Centre, London, ON; previ-
ously at Mt Sinai Hospital, Toronto, ON); David Brabyn (Royal Columbian 
Hospital, New Westminster, BC); David S.C. Lee (St Joseph's Health Cen-
tre; London, ON); Derek Matthew (Victoria General Hospital (Victoria, 
BC); Douglas D. McMillan (Foothill's Hospital, Calgary, AB); Christine New-
man (Hospital for Sick Children; Toronto, ON); Arne Ohlsson (Mt Sinai 
Hospital, Toronto, ON; formerly at Women's College Hospital, Toronto, 
ON); Abraham Peliowski (Royal Alexandra Hospital, Edmonton, AB); Mar-
garet Pendray (Children's & Women's Health Centre of British Columbia 
(Vancouver, BC); Koravangattu Sankaran, (Royal University Hospital, Sas-
katoon, SK); Barbara Schmidt (Hamilton Health Sciences Corporation, 
Hamilton, ON); Mary Seshia (Health Sciences Centre, Winnipeg, MB); 
Anne Synnes (Children's and Women's Health Centre of British Columbia, 
Vancouver, BC; formerly at Montreal Children's Hospital, Montreal, PQ); 
Paul Thiessen (Children's & Women's Health Centre of British Columbia 
(Vancouver, BC); Robin Walker (Children's Hospital of Eastern Ontario 
and Ottawa General Hospital, Ottawa, ON); Robin Whyte (IWK-Grace 
Health Centre for Women, Children and Families, Halifax, NS); Catherine 
M. G. Cronin (Winnipeg Regional Health Authority).
Coordinating centre staff (Vancouver, BC): Aireen Wingert; Stella 
Karuri; Sarka Lisonkova.
Actuarial survival curves by gestational age, with 95% CI Figure 6
Actuarial survival curves by gestational age, with 95% CI.BMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 9 of 13
(page number not for citation purposes)
Actuarial survival curves stratified by birth weight category;  by Gender Figure 7
Actuarial survival curves stratified by birth weight category; 
by Gender.BMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 10 of 13
(page number not for citation purposes)
Actuarial survival curves by sex Figure 9
Actuarial survival curves by sex.
Actuarial survival curves by birth weight category Figure 8
Actuarial survival curves by birth weight category.
<600
900-999
1300-1399
600-699
1000-1099
1400-1499
700-799
1100-1199
800-899
1200-1299BMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 11 of 13
(page number not for citation purposes)
References
1. Hack M, Wright LL, Shankaran S, Tyson JE, Horbar JD, Bauer CR,
Younes N: Very low birth weight outcomes of the National
Institute of Child Health and Human Development Neonatal
Network, November 1989 to October 1990.  Am J Obstet Gyne-
col 1995, 172:457-464.
2. Fanaroff AA, Wright LL, Stevenson DK, Shankaran S, Donovan EP,
Ehrenkranz RA, Younes N, Korones SB, Stoll BJ, Tyson JE, Bauer CR,
Oh W, Lemons JA, Papile LA, Verter J: Very low birthweight out-
comes of the National Institute of Child Health and Human
Development Neonatal Research Network, May 1991
through December 1992.  Am J Obstet Gynecol 1995,
173:1423-1431.
3. Stevenson DK, Wright LL, Lemons JA, Oh W, Korones SB, Papile LA,
Bauer CR, Stoll BJ, Tyson JE, Shankaran S, Fanaroff AA, Donovan EF,
Ehrenkranz RA, Verter J: Very low birth weight outcomes of the
National Institute of Child Health and Human Development
Neonatal Research Network, January 1993 through Decem-
ber 1994.  Am J Obstet Gynecol 1998, 179:1632-1639.
4. Ferrara TB, Hoekstra RE, Couser RJ, Gaziano EP, Calvin SE, Payne
NR, Fangman JJ: Survival and follow-up of infants born at 23–26
weeks of gestational age: effects of surfactant therapy.  J Pedi-
atr 1994, 124:119-124.
5. Jobe AH, Mitchell BR, Gunkel JH: Beneficial effects of the com-
bined use of prenatal corticosteroids and postnatal sur-
factant on preterm infants.  Am J Obstet Gynecol 1993,
168:508-513.
6. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W:
Decreased mortality rate among small premature infants
treated at birth with a single dose of synthetic surfactant: a
multicenter controlled trial. American Exosurf Pediatric
Study Group 1.  J Pediatr 1991, 118:277-284.
7. O'Shea TM, Preisser JS, Klinepeter KL, Dillard RG: Trends in mor-
tality and cerebral palsy in a geographically based cohort of
very low birth weight neonates born between 1982 to 1994.
Pediatrics 1998, 101:642-647.
8. O'Shea TM, Klinepeter KL, Goldstein DJ, Jackson BW, Dillard RG:
Survival and developmental disability in infants with birth
weights of 501 to 800 grams, born between 1979 and 1994.
Pediatrics 1997, 100:982-986.
Probability of survival to discharge (y-axis), for male and  female infants surviving to a given day in the NICU (x-axis),  stratified by birth weight (g) Figure 11
Probability of survival to discharge (y-axis), for male and 
female infants surviving to a given day in the NICU (x-axis), 
stratified by birth weight (g).
0 2 04 06 08 0 1 0 0
Days
0
2
0
4
0
6
0
8
0
1
0
0
P
e
r
c
e
n
t
a
g
e
S
u
r
v
i
v
a
l
-
t
o
-
D
i
s
c
h
a
r
g
e
R
a
t
e
s
Male
<600
600-699
700-799
800-899
900-999
1000-1099
1100-1199
1200-1299
1300-1399
1400-1499
0 2 04 06 08 0 1 0 0
Days
0
2
0
4
0
6
0
8
0
1
0
0
P
e
r
c
e
n
t
a
g
e
S
u
r
v
i
v
a
l
-
t
o
-
D
i
s
c
h
a
r
g
e
R
a
t
e
s
Female
<600
600-699
700-799
800-899
900-999
1000-1099
1100-1199
1200-1299
1300-1399
1400-1499
Probability of survival to discharge (y-axis), for male and  female infants surviving to a given day in the NICU (x-axis),  stratified by gestation age Figure 10
Probability of survival to discharge (y-axis), for male and 
female infants surviving to a given day in the NICU (x-axis), 
stratified by gestation age.
0 2 04 06 08 0 1 0 0
Days
0
2
0
4
0
6
0
8
0
1
0
0
P
e
r
c
e
n
t
a
g
e
S
u
r
v
i
v
a
l
-
t
o
-
D
i
s
c
h
a
r
g
e
R
a
t
e
s
Male
23 weeks
24 weeks
25 weeks
26 weeks
27 weeks
28 weeks
29 weeks
30 weeks
0 2 04 06 08 0 1 0 0
Days
0
2
0
4
0
6
0
8
0
1
0
0
P
e
r
c
e
n
t
a
g
e
S
u
r
v
i
v
a
l
-
t
o
-
D
i
s
c
h
a
r
g
e
R
a
t
e
s
Female
23 weeks
24 weeks
25 weeks
26 weeks
27 weeks
28 weeks
29 weeks
30 weeksBMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 12 of 13
(page number not for citation purposes)
9. Cooke RWI: Trends in incidence of cranial ultrasound lesions
and cerebral palsy in very low birth weight infants 1982–93.
Arch Dis Child Fetal Neonatal Ed 1999, 80:F115-F117.
10. Wariyar U, Richmond S, Hey E: Pregnancy outcome at 24–31
weeks' gestation: neonatal survivors.  Arch Dis Child 1989,
64:678-686.
11. Synnes AR, Ling EW, Whitfield MF, Mackinnon M, Lopes L, Wong G,
Effer SB: Perinatal outcomes of a large cohort of extremely
low gestational age infants (twenty-three to twenty-eight
completed weeks of gestation).  J Pediatr 1994, 125:952-60.
12. Phelps DL, Brown DR, Tung B, Cassady G, McClead RE, Purohit DM,
Palmer EA: 28-Day Survival Rates of 6676 Neonates with Birth
Weights of 1250 Grams or Less.  Pediatrics 1991, 87:7-17.
13. Draper ES, Manktelow B, Field DJ, James D: Prediction of survival
for preterm births by weight and gestational age: retrospec-
tive population based study.  BMJ 1999, 319:1093-1097.
14. Hack M, Horbar JD, Malloy MH, Tyson JE, Wright E, Wright L: Very
low birth weight outcomes of the National Institute of Child
Health and Human Development Neonatal Network.  Pediat-
rics 1991, 87:587-597.
15. Tyson JE, Younes N, Verter J, Wright LL: Viability, morbidity, and
resource use among newborns of 501 to 800 g birth weight.
National Institute of Child Health and Human Development
Neonatal Research Network.  JAMA 1996, 276:1645-1651.
16. Brothwood M, Wolke D, Gamsu H, Benson J, Cooper D: Prognosis
of the very low birth weight baby in relation to gender.  Arch
Dis Child 1986, 61:559-564.
17. Resnick MB, Carter RL, Ariet M, Bucciarelli RL, Evans JH, Furlough
RR, Ausbon WW, Curran JS: Effect of birth weight, race, and sex
on survival of low-birth-weight infants in neonatal intensive
care.  Am J Obstet Gynecol 1989, 161:184-7.
18. Hoffman EL, Bennett FC: Birth Weight Less than 800 Grams:
Changing Outcomes and Influences of Gender and Gestation
Number.  Pediatrics 1990, 86:27-34.
19. Khoury MJ, Marks JS, McCarthy BJ, Zaro SM: Factors affecting the
sex differential in neonatal mortality: The role of respiratory
distress syndrome.  Am J Obstet Gynecol 1985, 151:777-782.
20. Cartlidge PHT, Stewart JH: Survival of very low birth weight and
very preterm infants in a geographically defined population.
Acta Paediatrica 1997, 86:105-110.
21. Cooper TR, Berseth CL, Adams JM, Weisman LE: Actuarial sur-
vival in the Premature Infant Less than 30 Weeks' Gestation.
Pediatrics 1998, 101:975-978.
22. Meadow W, Reimshisel T, Lantos J: Birth weight specific mortal-
ity for extremely low birth weight infants vanishes by four
days of life: epidemiology and ethics in the neonatal intensive
care unit.  Pediatrics 1996, 97:636-643.
23. Gould JB, Benitz WE, Liu H: Mortality and time to death in very
low birth weight infants: California, 1987 and 1993.  Pediatrics
2000, 105:e37.
24. Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R,
Chien LY, Sale J: Variations in practice and outcomes of the
Canadian NICU Network 1996–7.  Pediatrics 2000, 106:1070-9.
25.  [http://www.statcan.ca/english/Pgdb/demo03.htm].
26. Synnes A, Berry M, Jones H, Pendray M, Stewart SD, Lee SK, for The
Canadian Neonatal Network: Infants with congenital anomalies
admitted to neonatal intensive care units.  Am J Perinatology
2004, 21:199-208.
27. Richardson DK, Corcoran JD, Escobar GJ, Lee SK, for the Canadian
NICU Network the Kaiser Permanente Neonatal Minimum Sata Set
Wide Area Network and the SNAP-II Study Group: SNAP-II and
SNAPPE-II: Simplified newborn illness severity and mortal-
ity risk scores.  J Pediatr 2001, 138:92-100.
28. Gray JE, Richardson DK, McCormick MC, Workman-Daniels K,
Goldman DA: Neonatal therapeutic intervention scoring sys-
tem (NTISS): a therapy-based severity of illness assessment
tool.  Pediatrics 1992, 90:561-567.
29. Canadian Neonatal Network Abstractor Manual, Vancouver, BC 1995.
30. Arbuckle TE, Sherman GJ: An analysis of birth weight by gesta-
tional age in Canada.  CMAJ 1989, 140:157-165.
31. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM: Abnor-
mal pulmonary outcomes in preterm infants: prediction
from oxygen requirement in the neonatal period.  Pediatrics
1988, 82:527-532.
32. Papile LA, Munsick-Bruno G, Schaefer A: Relationship of cerebral
intra-ventricular hemorrhage and early childhood handi-
caps.  J Pediatr 1983, 103:272-277.
33. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L,
Brotherton T: Neonatal necrotizing enterocolitis. Therapeu-
tic decisions based upon clinical staging.  Ann Surg 1978,
187:1-7.
34. Committee members: An international classification of retinop-
athy of prematurity.  Pediatrics 1984, 74:127-133.
35. Reese AB, King MJ, Owens WC: a classification of retrolental
fibroplasia.  Am J Opthalmol 1953, 36:1333.
36. Freeman J, Epstein MF, Smith NE, Platt R, Sidebottom DG, Goldman
DA: Extra hospital stay and antibiotic usage with nocosomial
coagulase negative staphylococcal bacteremia in two neona-
tal intensive care unit populations.  Am J Dis Child 1990,
144:324-329.
37. WHO International Classification of Diseases, 9 th Revision. WHO, Geneva
1975.
38. Horbar JD, Badger J, Lewit EM, Rogowski J, Shiono PH: Hospital and
patient characteristics associated with variation in 28-day
mortality rates for very low birth weight infants.  Pediatrics
1997, 99:149-156.
39. The investigators of the Vermont-Oxford Trials Network: Very low
birth weight outcomes for 1990.  Pediatrics 1993, 91:540-545.
40. Donoghue D: Australia & New Zealand Neonatal Network
Neonatal Network Series Number 2.  AIHW National Perinatal
Statistics Unit, Sydney 1997. ISSN 1326-012X, AIHW Catalogue no.
PER 5
41. Tucker J, McGuire W: Epidemiology of preterm birth.  BMJ 2004,
329:675-678.
42. Battin M, Ling EW, Whitfield MF, Mackinnon M, Effer SB: Has the
outcome for extremely low gestational age (ELGA) infants
improved following recent advances in neonatal intensive
care?  Am J Perinatol 1998, 15:469-477.
43. Hack M, Fanaroff AA: Outcomes of children of extremely low
birthweight and gestational age in the 1990's.  Early Hum Devel
1999, 53:193-218.
44. Hack M, Friedman H, Fanaroff AA: Outcomes of extremely low
birth weight infants.  Pediatrics 1996, 98:931-937.
45. Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dex-
amethasone in preterm infants at high risk for bronchopul-
monary dysplasia.  N Engl J Med 1989, 320:1505-10.
46. Khosla SS, Brehier A, Eisenfeld AJ, Ingleson LD, Parks PA, Rooney SA:
Effects of estrogen on fetal rabbit lung maturation: morpho-
logical and biochemical studies.  Pediatr Res 1981, 15:1274-1281.
47. Zachman RD, Morison JC, Curet LB, Gustafson N, the Collaborative
Group on Antenatal Steroid Therapy: Lecithin:sphingomyelin
ratio in the amniotic fluid of male and female fetuses.  J Reprod
Med 1989, 34:203-206.
48. Nielson HC: Testosterone regulation of sex differences in
fetal lung development.  Proc Soc Exp Biol Med 1992, 199:446-452.
49. Chien LY, Ohlsson A, Seshia M, Boulton J, Sankaran K, Lee SK, The
Canadian Neonatal Network: Variation in antenatal corticoster-
oid treatment – a persistent problem 30 years later.  Obstetr
& Gynecol 2002, 99:401-408.
50. Chan KJ, Ohlsson A, Synnes A, Lee DSC, Chien LY, Lee SK, The
Canadian NICU Network: Survival, morbidity and resource use
of <25 weeks gestation infants.  Am J Obstet Gynecol 2001,
185:220-226.
51. Synnes A, Chien LY, Peliowski A, Baboolal R, Lee SK, The Canadian
Neonatal Network: Variations in Intraventricular Hemorrhage
Incidence Rates among Canadian Neonatal Intensive Care
Units.  J Pediatr 2001, 138:525-531.
52. Chien LY, Whyte R, Thiessen P, Matthew D, Aziz K, Lee SK, The
Canadian Neonatal Network: Improved outcome of preterm
infants when delivered in tertiary care centers.  Obstet & Gyne-
col 2001, 98:247-252.
53. Lee SK, McMillan DD, Ohlsson A, Boulton J, Lee DSC, Ting S, Liston
R, The Canadian Neonatal Network: Benefit of preterm birth at
tertiary care centers is related to gestational age.  Am J Obstet
Gynecol 2003, 188:617-622.
54. Lee SK, Lee DCS, Andrews WL, Baboolal R, Pendray M, Stewart SD,
The Canadian Neonatal Network: Higher mortality among
infants admitted to neonatal intensive care units at nights.  J
Pediatr 2003, 143:592-597.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pediatrics 2005, 5:40 http://www.biomedcentral.com/1471-2431/5/40
Page 13 of 13
(page number not for citation purposes)
55. Sankaran K, Puckett B, Lee DSC, Seshia M, Boulton J, Qiu ZG, Lee SK,
Canadian Neonatal Network: Variations in incidence of necro-
tizing enterocolitis in Canadian neonatal intensive care
units.  J Pediatr Gastro Nutr 2004, 39:366-372.
56. Hayter M, Anderson L, Claydon J, Magee LA, Little R, Liston RM, Lee
SK, Dadelszen PV, Canadian Neonatal Network: Variations in early
and intermediate neonatal outcomes for inborn babies
admitted to a Canadian NICU and born of hypertensive
pregnancies.  JOGC 2005, 27:25-32.
57. Shah P, Shah V, Qiu ZG, Ohlsson A, Lee SK, Canadian Neonatal Net-
work:  Improved outcomes of outborn preterm infants if
admitted to perinatal centers vs free-standing pediatric hos-
pitals.  J Pediatr 2005, 146:626-631.
58. Lau J, Magee F, Qiu ZG, Hoube J, von Dadelszen P, Lee SK: Mater-
nal-fetal chorioamnionitis is associated with higher neonatal
mortality, morbidity and resource use than maternal chori-
oamnionitis.  Am J Obstet Gynecol 2005, 193:708-713.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2431/5/40/prepub